Investigation of the changes in hepatic 5-hydroxytryptamine 2A receptor levels caused by lipopolysaccharide of Porphyromonas gingivalis and the effect of Thymoquinone on these changes.
- 31 August 2025
- journal article
- Published by Journal of Advances in VetBio Science and Techniques in Journal of Advances in VetBio Science and Techniques
- Vol. 10 (2) , 108-114
Abstract
Background: The present study aimed to assess the effect of Porphyromonas gingivalis-Lipopolysaccharide (P.gingivalis-LPS) on hepatic disorder mediated by 5-hydroxytryptamine receptor 2A (HT2AR) and whether there is any impact of Thymoquinone (TQ) administration. Methods: 10 µl P. gingivalis-LPS (1mg/ml) injected 6 times at 48-hour intervals into the palatal gingiva of rats. TQ was given by oral gavage (10 mg/kg per day) for two weeks. HT2AR and pro-caspase-3 levels were measured by the enzyme-linked immunosorbent assay (ELISA). Morphological changes in the liver were identified by hematoxylin and eosin staining. Results: In the P.gingivalis-LPS injected group, the hepatic HT2AR levels increased while pro-caspase-3 levels decreased, disturbing the liver morphological structure. TQ administration increased pro-caspase-3 levels and improved morphological structure despite increased HT2AR levels. Conclusion: Our results suggest that oral application of P. gingivalis-LPS decreased pro-caspase 3, an inactive form of caspase-3 by HT2AR, probably due to increased cleaved caspase-3 levels, and TQ administration increased pro-caspase-3 levels, leading to improved liver morphological structure. Therephore, our study indicated that oral pathogen P. gingivalis might impact the liver HT2AR-mediated, and TQ may have a beneficial effect.Keywords
This publication has 30 references indexed in Scilit:
- Theabrownin inhibits obesity and non-alcoholic fatty liver disease in mice via serotonin-related signaling pathways and gut-liver axisJournal of Advanced Research, 2023
- Liquid chromatography method with tandem mass spectrometry and fluorescence detection for determination of inflammatory biomarkers in gingival crevicular fluid as a tool for diagnosis of periodontal diseaseJournal of Pharmaceutical and Biomedical Analysis, 2022
- Thymoquinone in autoimmune diseases: Therapeutic potential and molecular mechanismsBiomedicine & Pharmacotherapy, 2021
- Thymoquinone attenuates oxidative stress of kidney mitochondria and exerts nephroprotective effects in oxonic acid‐induced hyperuricemia ratsBioFactors, 2019
- Porphyromonas gingivalis lipopolysaccharide-induced periodontitis and serum amyloid-beta peptidesArchives of Oral Biology, 2019
- Association between periodontal pathogens and systemic diseaseBiomedical Journal, 2019
- Resveratrol prevents alveolar bone loss in an experimental rat model of periodontitisActa Biomaterialia, 2016
- Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathyHepatology, 2015
- Diabetes Mellitus and InflammationCurrent Diabetes Reports, 2013
- Blood and Plasma 5–Hydroxytryptamine Levels in Patients With CirrhosisHepatology, 1994